Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 7;21(4):224-229.
doi: 10.18502/cjn.v21i4.11719.

The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy

Jafar Mehvari-Habibabadi  1 , Mohammad Zare  1 , Mohammad Reza Aghaye-Ghazvini  2 , Maryam Rahnama  1
Affiliations

The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy

Jafar Mehvari-Habibabadi et al. Curr J Neurol. .

Abstract

Background: Levetiracetam (LEV) is approved for treating epilepsy. The current evidence shows that LEV can cause behavioral problems such as depression. It is well-known that depression is associated with oxidative stress. Therefore, we conducted this study to assess the influence of LEV on depression severity and anti-oxidant status. Methods: In this prospective longitudinal study, 50 patients with diagnosis of epilepsy on LEV were included. We used Beck Depression Inventory-II (BDI-II) to assess depression severity. The serum levels of zinc and glutathione were measured as anti-oxidant markers. These variables were evaluated at the baseline and 3 months after the commencement of LEV. Results: A total of 30 patients finished the follow-up. Among them, 21 patients were women. The mean age at baseline was 28.76 ± 11.37 (range: 16-68 years). The severity of depression at the last follow-up was significantly higher than the baseline. We observed a decrease in the serum levels of zinc and glutathione, though they were not statistically significant. Conclusion: Our results suggest that LEV can increase the risk of depression in patients with epilepsy. This study also suggests that zinc depletion can be induced through act of LEV. Further studies are needed to validate these findings.

Keywords: Depression; Epilepsy; Glutathione; Oxidative Stress; Zinc.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest in this study.

Figures

Figure 1
Figure 1
The study flowchart
See this image and copyright information in PMC

References

    1. Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology. 2020;168:107966. - PubMed
    1. Manreza MLG, Pan TA, Carbone EQ, Vattimo ACA, Herrera R, Morais DC, et al. Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy. Arq Neuropsiquiatr. 2021;79(4):290–8. - PMC - PubMed
    1. Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, et al. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: An open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021;397(10282):1363–74. - PMC - PubMed
    1. Lee SK, Lee SA, Kim DW, Loesch C, Pelgrims B, Osakabe T, et al. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea. Epilepsy Behav. 2019;97:67–74. - PubMed
    1. Steinhoff BJ, Klein P, Klitgaard H, Laloyaux C, Moseley BD, Ricchetti-Masterson K, et al. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review. Epilepsy Behav. 2021;118:107939. - PubMed

LinkOut - more resources